Abstract
Neovascular ocular diseases (age-related macular degeneration, retinopathy of prematurity, and diabetic retinopathy) are the leading causes of blindness and are characterized by excessive new blood vessels either as choroidal neovascularization (CNV) or retinal neovascularization (RNV) which can be induced by the imbalance of growth factors. Animal models for these diseases provide valuable tools for studying the pathology, physiology, and mechanisms by which genes function and regulate these disease phenotypes. In this paper, we will review some recent studies using animal models and therapeutic treatments of these diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Afzal A, Caballero S, Palii SS et al (2010) Targeting retinal and choroid neovascularization using the small molecule inhibitor carboxyamidotriazole. Brain Res Bull 81:320–326
Barber AJ, Antonetti DA, Kern TS et al (2005) The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 46:2210–2218
Benny O, Nakai K, Yoshimura T et al (2010) Broad spectrum antiangiogenic treatment for ocular neovascular diseases. PLoS One 5 pII:e12515
Bird AC (2010) Therapeutic targets in age-related macular disease. J Clin Invest 120:3033–3041
Chen J, Patil S, Seal S et al (2006) Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol 1:142–150
Chen Y, Hu Y, Zhou T et al (2009) Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. Am J Pathol 175:2676–2685
Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376:124–136
Dorrell MI, Aguilar E, Jacobson R et al (2009) Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress. J Clin Invest 119:611–623
Edwards AO, Malek G (2007) Molecular genetics of AMD and current animal models. Angiogenesis 10:119–132
Ellis-Behnke R, Jonas JB (2011) Redefining tissue engineering for nanomedicine in ophthalmology. Acta Ophthalmol e108–e114
Friedlander M (2009) Combination angiostatic therapies: targeting multiple angiogenic pathways. Retina 29:S27-29
Gibson DL, Sheps SB, Schechter MT et al (1989) Retinopathy of prematurity: a new epidemic? Pediatrics 83:486–492
Grossniklaus HE, Kang SJ, Berglin L (2010) Animal models of choroidal and retinal neovascularization. Prog Retin Eye Res 29:500–519
Hu W, Jiang A, Liang J et al (2008) Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model’s retinal angiomatous proliferation. Invest Ophthalmol Vis Sci 49:407–415
Jiang J, Xia XB, Xu HZ et al (2009) Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF. J Cell Physiol 218:66–74
Lai CM, Dunlop SA, May LA et al (2005a) Generation of transgenic mice with mild and severe retinal neovascularisation. Br J Ophthalmol 89:911–916
Lai CM, Shen WY, Brankov M et al (2005b) Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys. Mol Ther 12:659–668
Lamartina S, Cimino M, Roscilli G et al (2007) Helper-dependent adenovirus for the gene therapy of proliferative retinopathies: stable gene transfer, regulated gene expression and therapeutic efficacy. J Gene Med 9:862–874
Limae Silva R, Shen J, Gong YY et al (2010) Agents that bind annexin A2 suppress ocular neovascularization. J Cell Physiol 225:855–864
Liu X, Wang D, Liu Y et al (2010) Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model. Invest Ophthalmol Vis Sci 51:3749–3757
Marchetti V, Krohne TU, Friedlander DF et al (2010) Stemming vision loss with stem cells. J Clin Invest 120:3012–3021
Ohno-Matsui K, Hirose A, Yamamoto S et al (2002) Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment. Am J Pathol 160:711–719
Otani A, Kinder K, Ewalt K et al (2002) Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med 8:1004–1010
Pechan P, Rubin H, Lukason M et al (2009) Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization. Gene Ther 16:10–16
Ricci B (1990) Oxygen-induced retinopathy in the rat model. Doc Ophthalmol 74:171–177
Ritter MR, Banin E, Moreno SK et al (2006) Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J Clin Invest 116:3266–3276
Rokoczy E, Rashman I, Binz N et al (2010) Characterization of a mouse model of hyperglycemia and retinal neovascularization. Am J Pathol 177
Sapieha P, Joyal JS, Rivera JC et al (2010) Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. J Clin Invest 120:3022–3032
Singh S, Kumar A, Karakoti A, et al. (2010) Unveiling the mechanism of uptake and sub-cellular distribution of cerium oxide nanoparticles. Mol Biosyst 6:1813–1820
Takeda A, Baffi JZ, Kleinman ME et al (2009) CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 460:225–230
Tobe T, Ortega S, Luna JD et al (1998) Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 153:1641–1646
Xie B, Shen J, Dong A et al (2009) Blockade of sphingosine-1-phosphate reduces macrophage influx and retinal and choroidal neovascularization. J Cell Physiol 218:192–198
Xiong SQ, Xia XB, Xu HZ et al (2009) Suppression of retinal neovascularization by small-Âinterference RNA targeting erythropoietin. Ophthalmologica 223:306–312
Yoshioka M, Kayo T, Ikeda T et al (1997) A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46:887–894
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this paper
Cite this paper
Cai, X., Sezate, S.A., McGinnis, J.F. (2012). Neovascularization: Ocular Diseases, Animal Models and Therapies. In: LaVail, M., Ash, J., Anderson, R., Hollyfield, J., Grimm, C. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 723. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-0631-0_32
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0631-0_32
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-0630-3
Online ISBN: 978-1-4614-0631-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)